Development, manufacturing, and distribution of generic, biosimilar, and value-added medicines across various therapeutic fields, including oncology, cardiology, neurology, psychiatry, diabetes, pain management, and gastroenterology.
B
CSR Analysis score
The organization is among the top 20% of most committed organizations, excluding the top 5%, among comparable organizations.
+160,000
Total organizations analyzedAnalysis by axis
Access the detailed report with all sector benchmarks, in-depth competitive analysis and actionable recommendations.
Methodology: Score calculated according to 6 CSR themes (Carbon, Biodiversity, Circular Economy, Sustainable Investments, Governance, Social Impact)
Sources: Public data, CSR reports, documented initiatives, official databases
Last update: June 2026
This analysis is not yet available in English. Please see the French version.
Leading organizations
Apotex
B
Development and commercialization of generic, biosimilar, and specialty pharmaceuticals across various therapeutic areas, including dermatology, neuroscience, oncology, ophthalmology, osteoporosis, pain management, and women's health.
Zentiva
A
Development, production, and distribution of generic high-quality and affordable medicines. Focus on key therapeutic areas such as cardiology, diabetes, oncology, respiratory diseases, central nervous system, and public health.
Teva
B
Development, production, and marketing of generic drugs, biosimilars, and innovative medicines.
Initiatives identified among leaders
Adhésion à labels et certifications (UNGC, SBTi, EcoVadis, PSCI) pour alignement stratégique.
“Zentiva adhère à plusieurs labels et certification...” - ZentivaSuivi des indicateurs de sécurité et conformité réglementaire amélioré.
“Apotex US a introduit en 2024 la 'Pyramide de Sécu...” - ApotexRéaffirmation de l'engagement envers les objectifs Healthy Future incluant énergies renouvelables et gestion des déchets.
“Lors d'une visite en Allemagne en 2024, le CEO de ...” - Teva76% of similar organizations communicate on CSR issues
+910 initiatives collected from 50 similar organizations
Is your score incomplete? Update your CSR information and improve your positioning.
Claim this page
Updated data
Personalized recommendations
Access complete data, competitive analyses and actionable recommendations for your clients.
Comprehensive sector benchmarks
Competitive data
Ready-to-use reports